ATE208209T1 - Die kombination des wachstumhormones und des insulinähnlichen wachstumsfaktors-i zur behandlung von kongestivem herzversagen - Google Patents
Die kombination des wachstumhormones und des insulinähnlichen wachstumsfaktors-i zur behandlung von kongestivem herzversagenInfo
- Publication number
- ATE208209T1 ATE208209T1 AT95914882T AT95914882T ATE208209T1 AT E208209 T1 ATE208209 T1 AT E208209T1 AT 95914882 T AT95914882 T AT 95914882T AT 95914882 T AT95914882 T AT 95914882T AT E208209 T1 ATE208209 T1 AT E208209T1
- Authority
- AT
- Austria
- Prior art keywords
- combination
- mammal
- heart failure
- congestive heart
- insulin
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 4
- 108010051696 Growth Hormone Proteins 0.000 title abstract 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 4
- 239000000122 growth hormone Substances 0.000 title abstract 4
- 206010007559 Cardiac failure congestive Diseases 0.000 title abstract 3
- 206010019280 Heart failures Diseases 0.000 title abstract 3
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 abstract 5
- 230000000747 cardiac effect Effects 0.000 abstract 2
- 230000002107 myocardial effect Effects 0.000 abstract 2
- 239000005541 ACE inhibitor Substances 0.000 abstract 1
- 102000013275 Somatomedins Human genes 0.000 abstract 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22792394A | 1994-04-15 | 1994-04-15 | |
| US08/284,859 US5661122A (en) | 1994-04-15 | 1994-08-02 | Treatment of congestive heart failure |
| US08/333,909 US5610134A (en) | 1994-04-15 | 1994-11-03 | Treatment of congestive heart failure |
| PCT/US1995/003755 WO1995028174A1 (en) | 1994-04-15 | 1995-03-30 | The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE208209T1 true ATE208209T1 (de) | 2001-11-15 |
Family
ID=27397790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95914882T ATE208209T1 (de) | 1994-04-15 | 1995-03-30 | Die kombination des wachstumhormones und des insulinähnlichen wachstumsfaktors-i zur behandlung von kongestivem herzversagen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5610134A (de) |
| EP (1) | EP0755265B1 (de) |
| JP (1) | JP3473623B2 (de) |
| AT (1) | ATE208209T1 (de) |
| AU (1) | AU691273B2 (de) |
| CA (1) | CA2185998C (de) |
| DE (1) | DE69523747T2 (de) |
| DK (1) | DK0755265T3 (de) |
| ES (1) | ES2167427T3 (de) |
| HK (1) | HK1003418A1 (de) |
| LV (1) | LV12966B (de) |
| PT (1) | PT755265E (de) |
| WO (1) | WO1995028174A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3182307B2 (ja) * | 1994-12-27 | 2001-07-03 | 株式会社荏原製作所 | 全周流型ポンプ |
| US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| AU2334097A (en) * | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
| US6306826B1 (en) | 1997-06-04 | 2001-10-23 | The Regents Of The University Of California | Treatment of heart failure with growth hormone |
| US6015384A (en) * | 1998-08-31 | 2000-01-18 | Acuson Corporation | Ultrasonic system and method for tissue viability imaging |
| SE9901634D0 (sv) * | 1999-05-05 | 1999-05-05 | Sahltech Ab | Treatment of myocardial infarction with a substance related to the growth hormone axis |
| JP2003504343A (ja) * | 1999-07-12 | 2003-02-04 | ジェネンテック・インコーポレーテッド | 腫瘍壊死因子リガンド／レセプター相同体による血管形成及び心血管形成の促進と抑制 |
| CA2378949C (en) * | 1999-07-12 | 2015-03-31 | Grandis Biotech Gmbh | Growth hormone formulations |
| WO2001059100A2 (en) * | 2000-02-11 | 2001-08-16 | Genentech, Inc. | Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| FR2805051B1 (fr) * | 2000-02-14 | 2002-12-06 | Geophysique Cie Gle | Methode de surveillance sismique d'une zone souterraine par utilisation simultanee de plusieurs sources vibrosismiques |
| EP2792747A1 (de) | 2000-06-23 | 2014-10-22 | Genentech, Inc. | Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese |
| CA2648051A1 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US7547674B2 (en) | 2001-06-06 | 2009-06-16 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| US7862810B2 (en) | 2000-07-31 | 2011-01-04 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| WO2002009650A2 (en) | 2000-07-31 | 2002-02-07 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| US20030224984A1 (en) * | 2001-06-20 | 2003-12-04 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US6607517B1 (en) | 2001-08-24 | 2003-08-19 | Radiant Medical, Inc. | Method of inotropic treatment of heart disease using hypothermia |
| KR20050090430A (ko) | 2002-12-31 | 2005-09-13 | 알투스 파마슈티컬스 인코포레이티드 | 인간 성장 호르몬 결정 및 이것의 제조 방법 |
| US20080103457A1 (en) * | 2005-01-11 | 2008-05-01 | Heart Failure Technologies, Inc. University Enterprise Laboratories (Uel) | Method and System for Treating Heart Failure |
| AU2008323719B2 (en) | 2007-11-09 | 2013-04-04 | New York Medical College | Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor |
| AU2008334058B2 (en) | 2007-11-30 | 2014-07-10 | New York Medical College | Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| US8512696B2 (en) | 2007-11-30 | 2013-08-20 | Autologous, Llc | Methods of isolating non-senescent cardiac stem cells and uses thereof |
| EP2225362A1 (de) | 2007-11-30 | 2010-09-08 | New York Medical College | Verfahren zur verminderung von transplantatabstossung und herz-allotransplantat-vaskulopathie mittels implantieren autologer stammzellen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| WO1992007578A1 (en) * | 1990-10-25 | 1992-05-14 | Genentech, Inc. | Use of protective agents against reactive oxygen species |
| SE9100099D0 (sv) * | 1991-01-11 | 1991-01-11 | Kabi Pharmacia Ab | Use of growth factor |
| SE9101840L (sv) * | 1991-06-14 | 1992-12-15 | Kabi Pharmacia | Ny medicinsk anvaendning |
| WO1993000109A1 (en) * | 1991-06-28 | 1993-01-07 | Genentech, Inc. | Method of stimulating immune response using growth hormone |
| US5202119A (en) * | 1991-06-28 | 1993-04-13 | Genentech, Inc. | Method of stimulating immune response |
-
1994
- 1994-11-03 US US08/333,909 patent/US5610134A/en not_active Expired - Lifetime
-
1995
- 1995-03-30 EP EP95914882A patent/EP0755265B1/de not_active Expired - Lifetime
- 1995-03-30 WO PCT/US1995/003755 patent/WO1995028174A1/en active IP Right Grant
- 1995-03-30 PT PT95914882T patent/PT755265E/pt unknown
- 1995-03-30 AT AT95914882T patent/ATE208209T1/de active
- 1995-03-30 DK DK95914882T patent/DK0755265T3/da active
- 1995-03-30 AU AU21956/95A patent/AU691273B2/en not_active Expired
- 1995-03-30 CA CA2185998A patent/CA2185998C/en not_active Expired - Lifetime
- 1995-03-30 ES ES95914882T patent/ES2167427T3/es not_active Expired - Lifetime
- 1995-03-30 DE DE69523747T patent/DE69523747T2/de not_active Expired - Lifetime
- 1995-03-30 JP JP52697595A patent/JP3473623B2/ja not_active Expired - Lifetime
-
1998
- 1998-03-24 HK HK98102461A patent/HK1003418A1/xx not_active IP Right Cessation
-
2002
- 2002-10-15 LV LVP-02-184A patent/LV12966B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0755265B1 (de) | 2001-11-07 |
| HK1003418A1 (en) | 1998-10-30 |
| JP3473623B2 (ja) | 2003-12-08 |
| ES2167427T3 (es) | 2002-05-16 |
| US5610134A (en) | 1997-03-11 |
| AU2195695A (en) | 1995-11-10 |
| DE69523747D1 (de) | 2001-12-13 |
| LV12966B (en) | 2003-05-20 |
| PT755265E (pt) | 2002-04-29 |
| DK0755265T3 (da) | 2002-03-04 |
| CA2185998C (en) | 2011-02-22 |
| CA2185998A1 (en) | 1995-10-26 |
| DE69523747T2 (de) | 2002-08-01 |
| EP0755265A1 (de) | 1997-01-29 |
| AU691273B2 (en) | 1998-05-14 |
| WO1995028174A1 (en) | 1995-10-26 |
| JPH09512008A (ja) | 1997-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE208209T1 (de) | Die kombination des wachstumhormones und des insulinähnlichen wachstumsfaktors-i zur behandlung von kongestivem herzversagen | |
| DE69616376D1 (de) | Verwendung von Tiagabin zur Behandlung von Schlafstörungen | |
| DE69805973D1 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase | |
| ATE141799T1 (de) | Die kombination des wachshormons und des insulin- ähnlichen wachstumsfaktors-i stimuliert das wachstum | |
| DE69632236D1 (de) | Verwendung von dha in der behandlung von dyslexie | |
| DE69230789D1 (de) | Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten | |
| ATE203165T1 (de) | Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndromes | |
| ES2140463T3 (es) | Prevencion y tratamiento de la neuropatia periferica. | |
| DE69807349D1 (de) | Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| ATE374618T1 (de) | Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen | |
| ATE215835T1 (de) | Verfahren zur systemischen behandlung katabolischer zustände und systemischer gewebeschädigung | |
| ATE201598T1 (de) | Verwendung von moxonidin zur behandlung neuropathischer schmerzen | |
| ATE224187T1 (de) | Verfahren zur vorbeugung und behandlung des myokardialen stunnings | |
| ATE121296T1 (de) | Igf-i zur behandlung von nebeneffekten der steroidtherapie. | |
| ATE228006T1 (de) | Verwendung von vip zur erstellung eines medikamentes zur behandlung des endotoxischen schocks in säugetieren | |
| ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| CA2136953A1 (en) | A method for using lipoprotein associated coagulation inhibitor to treat sepsis | |
| ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
| MX9604803A (es) | Combinacion de hormona del crecimiento y factor de crecimiento similar a insulina para el tratamiento del fallo cardiaco congestivo. | |
| ATE58456T1 (de) | Zusammensetzung zur behandlung von laeuseplagen. | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| DE50009220D1 (de) | Verwendung von moxonidin zur behandlung nach herzinfarkt | |
| RU94042315A (ru) | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки | |
| UA23098A (uk) | Спосіб приготуваhhя морфологічhих препаратів для імуhоцитохімічhого досліджеhhя |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |